Asthma Management and Control in Portuguese Speaking Countries
DOI:
https://doi.org/10.20344/amp.11927Keywords:
Asthma, Brazil, Disease Management, Mozambique, PortugalAbstract
Introduction: Asthma affects more than 339 million people worldwide. In the Community of Portuguese Speaking Countries, in 2016, its prevalence ranged from 9.5% (Portugal) to 3.91% (Brazil). Chronic disease management programs aim to improve the health status of patients with chronic disease and reduce associated costs. The objective of this study is to identify models of asthma asthma ‘management and control’ that are that are implemented in the Community of Portuguese Speaking Countries (CPLP), and analyse them through the integrated disease management model.
Material and Methods: A rapid review of the PubMed indexed scientific literature and grey literature on ‘management and control of asthma’ in the countries of the Community of Portuguese-Speaking Countries was carried out.
Results: Portugal, Brazil and Mozambique presented publications on ‘management and control of asthma’, at different stages of implementation. Clinical management and organization and service delivery are the dimensions of integrated disease management most
addressed in publications.
Discussion: The implementation of asthma management and control programs is influenced by health systems, care delivery structures, and the surrounding political and social environment. The dimensions of funding and information systems are the most difficult to implement given the degree of economic, social and technological development of most countries under study.
Conclusion: Only Portugal, Brazil and Mozambique adopted asthma integrated disease management as the main form of asthma management and control. The programs developed by these countries can constitute a model for asthma integrated disease management in the other countries under study.
Downloads
Published
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
